CAPR logo

Capricor Therapeutics (CAPR) Net Margin

Annual Net Margin

-88.52%
+1048.85%+92.22%

December 31, 2023


Summary


Performance

CAPR Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCAPRprofitabilitymetrics:

Quarterly Net Margin

-555.20%
-278.23%-100.45%

September 30, 2024


Summary


Performance

CAPR Quarterly Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCAPRprofitabilitymetrics:

Net Margin Formula

Net Margin =  Net Income
Revenue
✕ 100%

CAPR Net Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+92.2%-100.5%
3 y3 years+98.0%+31.0%
5 y5 years+90.3%+31.0%

CAPR Net Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+98.9%-8712.7%+31.0%
5 y5-yearat high+98.9%-8712.7%+97.6%
alltimeall time-197.1%+99.1%-1129.3%+99.9%

Capricor Therapeutics Net Margin History

DateAnnualQuarterly
Sep 2024
-
-555.20%(+100.5%)
Jun 2024
-
-276.97%(+38.8%)
Mar 2024
-
-199.60%(+3068.3%)
Dec 2023
-88.52%(-92.2%)
-6.30%(-93.9%)
Sep 2023
-
-103.31%(-45.1%)
Jun 2023
-
-188.04%(-27.7%)
Mar 2023
-
-260.10%(-67.7%)
Dec 2022
-1137.37%(-86.1%)
-804.34%(+100.9%)
Sep 2022
-
-400.30%(-82.8%)
Dec 2021
-8175.86%(+85.7%)
-
Jun 2021
-
-2326.65%(-81.6%)
Mar 2021
-
-12.62 K%(+74.7%)
Dec 2020
-4401.94%(+478.9%)
-7224.51%(-68.8%)
Sep 2020
-
-23.19 K%(+231.9%)
Jun 2020
-
-6987.31%(+522.4%)
Mar 2020
-
-1122.72%(+69.7%)
Dec 2019
-760.36%(-16.3%)
-661.60%(-41.5%)
Sep 2019
-
-1130.84%(+126.8%)
Jun 2019
-
-498.71%(-54.4%)
Mar 2019
-
-1092.97%(+117.3%)
Dec 2018
-908.91%(-1096.7%)
-503.00%(-73.3%)
Sep 2018
-
-1886.50%(+84.8%)
Jun 2018
-
-1020.78%(+11.2%)
Mar 2018
-
-917.73%(+5.1%)
Dec 2017
91.19%
-
Sep 2017
-
-873.04%(+150.5%)
DateAnnualQuarterly
Jun 2017
-
-348.45%(-16.3%)
Mar 2017
-
-416.28%(-37.0%)
Dec 2016
-589.53%(+73.1%)
-660.94%(-15.3%)
Sep 2016
-
-780.20%(+51.7%)
Jun 2016
-
-514.43%(+9.9%)
Mar 2016
-
-468.08%(+27.5%)
Dec 2015
-340.50%(+128.2%)
-367.12%(+14.9%)
Sep 2015
-
-319.48%(-6.8%)
Jun 2015
-
-342.65%(+2.7%)
Mar 2015
-
-333.71%(+80.3%)
Dec 2014
-149.20%(-58.6%)
-185.09%(+24.9%)
Sep 2014
-
-148.22%(+0.7%)
Jun 2014
-
-147.26%(+26.7%)
Mar 2014
-
-116.22%(-70.6%)
Mar 2012
-
-394.82%(-53.6%)
Dec 2011
-360.63%(-96.5%)
-851.35%(+505.0%)
Sep 2011
-
-140.72%(-44.7%)
Jun 2011
-
-254.49%(-95.3%)
Dec 2007
-10.16 K%(+1398.7%)
-
Sep 2007
-
-5471.80%(>+9900.0%)
Dec 2006
-677.98%(-8.4%)
-
Dec 2003
-739.79%(+445.0%)
-
Sep 2003
-
-3.80%(-100.0%)
Dec 2002
-135.73%
-
Jun 2002
-
-472.25 K%(<-9900.0%)
Mar 2002
-
53.94%

FAQ

  • What is Capricor Therapeutics annual net profit margin?
  • What is the all time high annual net margin for Capricor Therapeutics?
  • What is Capricor Therapeutics annual net margin year-on-year change?
  • What is Capricor Therapeutics quarterly net profit margin?
  • What is the all time high quarterly net margin for Capricor Therapeutics?
  • What is Capricor Therapeutics quarterly net margin year-on-year change?

What is Capricor Therapeutics annual net profit margin?

The current annual net margin of CAPR is -88.52%

What is the all time high annual net margin for Capricor Therapeutics?

Capricor Therapeutics all-time high annual net profit margin is 91.19%

What is Capricor Therapeutics annual net margin year-on-year change?

Over the past year, CAPR annual net profit margin has changed by +1048.85% (+92.22%)

What is Capricor Therapeutics quarterly net profit margin?

The current quarterly net margin of CAPR is -555.20%

What is the all time high quarterly net margin for Capricor Therapeutics?

Capricor Therapeutics all-time high quarterly net profit margin is 53.94%

What is Capricor Therapeutics quarterly net margin year-on-year change?

Over the past year, CAPR quarterly net profit margin has changed by -278.23% (-100.45%)